TSVC (formerly TEEC Angel Fund) is a Silicon Valley-based seed-stage venture capital firm founded in 2010 by Tsinghua alumni. It focuses on backing deep-tech founders in areas such as AI, robotics, advanced manufacturing, and energy systems, and was an early seed investor in Zoom, Carta, and Ginkgo Bioworks.
Deal activity increased 300% year-over-year (4 deals in the last 12 months). Average disclosed round size is $19.8M (across 27 rounds with reported amounts).
Portfolio
20
Fund Size
—
Top Stage
Seed
Last 12 Mo
4
Team
chun Xia
Founding Partner
LISHENG Wang
General Partner
Chiu Chau
Venture Partner
David Duan
Venture Partner
Iris Quan
Venture Partner
LARRY ZHANG
Venture Partner
Xisheng Zhang
Venture Partner
Charlene Li
Director of Strategic Partnerships
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Expert Intelligence | Seed | $4.7M | Feb 2026 |
 Angle Health | Series B | $134M | Dec 2025 |
| AAnglehealth | Seed | $4M | Dec 2025 |
 IndustrialMind.ai | Pre-Seed | $1.2M | Nov 2025 |
 Lumotive | Series B | $45M | Feb 2025 |
| Lumotive | Series B | — | Jan 2025 |
 Petal Surgical | Series A | $10M | Jan 2025 |
 Forta | Series A | $55M | Jan 2024 |
 LeadOptik | Seed | $5M | May 2023 |
| Angle Health | Series A | $58M | Jan 2023 |
 Kubit | Series A | $18M | Apr 2022 |
| AAnglehealth | Series A | $58M | Jan 2022 |
| Angle Health | Series A | $58M | Jan 2022 |
| Kubit | Series A | $18M | Jan 2022 |
 Deskimo | Seed | $3M | Nov 2021 |
 Preveta | Seed | $2M | Apr 2021 |
| AAppaegis | Unknown | $7.7M | Jan 2021 |
 Healthlane | Unknown | $2.4M | Sep 2020 |
 Bioeclipse Therapeutics | Unknown | $7.7M | Apr 2020 |
| Healthlane | Unknown | $2.4M | Jan 2020 |
| Bioeclipse Therapeutics | Unknown | $7.7M | Jun 2019 |
| BBioEclipse | Unknown | $7.7M | Jun 2019 |
 Zoom | Seed | $3M | — |
 Yardbook | Seed | $120K | — |
 SimpleCitizen | Unknown | $5.8M | — |
Top Co-Investors
Last updated: 7 October 2026